WHO ICTRP trial
A Clinical study to assess PK properties of iron isomaltoside 1000 (Monofer®)…
CTRI/2012/01/002319 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2012/01/002319 |
|---|---|
| Public title | A Clinical study to assess PK properties of iron isomaltoside 1000 (Monofer®) administered by 500 mg IV bolus injection or 1000 mg intravenous infusion to patients with Non-Dialysis Dependent Chronic Kidney Disease |
| Scientific title | A Open-label pharmacokinetic study of iron isomaltoside 1000 (Monofer®) administered by 500 mg IV bolus injection or 1000 mg intravenous infusion to patients with Non-Dialysis Dependent Chronic Kidney Disease - none |
| Primary sponsor | Pharmacosmos AS |
| Secondary sponsors | Max Neeman International |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- Non-Dialysis Dependent Chronic Kidney Disease (CKD) |
| Interventions | Intervention1: Iron isomaltoside 1000 (Monofer®): administered as 500 mg IV bolus injections Frequency: Once Daily Duration: Once in the Study Intervention2: Iron isomaltoside 1000 (Monofer®): administered as 1000 mg IV infusions… |
| Registration date | Mar 1, 2012 |
| Target size | 16 |
| Secondary IDs | P-Monofer-PK-CKD-03 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: